top of page
Search


The Resilience of Early-stage European Healthtech
Since 2020, the European healthtech landscape has changed almost beyond recognition. Demand for cutting-edge solutions has transcended the individual to touch the level of health systems, insurers and employers. The enterprise value of European healthtech start-ups has surged, outstripping Asia and the US, and Europe has emerged as a key, global player. Video and full report here: https://octopusventures.com/reports/the-resilience-of-early-stage-european-healthtech/ In The R

Matthieu Vallin


What data tells us about the trends shaping healthtech
In brief Matthieu Vallin takes a granular look at three years’ of available funding data to ask how the early-stage healthtech landscape is changing. The data shows that priorities are changing – the clinical element of AI is ever more important and scrutinised, consumer health platform are becoming more medicalised into virtual clinics, the lines between AI / automation / practice management software are blurring, and generative & large AI models are set to transform the ent

Matthieu Vallin


Mind & Machine: What’s next for neural interfaces?
Published article here: https://octopusventures.com/blog/the-future-of-wearable-therapies/ Introduction: We have so much to learn about the brain. Identifying which neurons or groups of neurons correspond to a specific action, thought, process or disease pathway is incredibly difficult. Every week we come across fascinating developments. Just a few weeks ago, researchers at MIT published their work on uncovering the neurons that encode outcomes of actions, i.e. the neurons th

Matthieu Vallin


Launching tech players into healthcare: 5 key learnings from a successful market-entry strategy
The board of a global Japanese technology firm had a bold ambition: to enter and disrupt the UK healthcare market. They hoped to do so by leveraging proprietary technology assets and forging breakthrough partnerships with startups and academic institutions and they chose Sia Partners to bridge the gap between ambition and action. The timing was right. Healthcare and pharmaceutical markets are currently being radically reshaped by a suite of technological advances in data scie

Matthieu Vallin


Health & Hygiene Rewired: The Opportunities Ahead in Consumer Health
Consumer health companies and startups can capitalize by rewiring our health and hygiene habits. 9 emerging consumer and technology...

Matthieu Vallin
bottom of page